PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2025 Earnings Call May 6, 2025 4:30 PM ET
Company Participants
Ellen Cavaleri - Head, Investor Relations
Matthew Klein - Chief Executive Officer
Eric Pauwels - Chief Business Officer
Pierre Gravier - Chief Financial Officer
Conference Call Participants
Kristen Kluska - Cantor Fitzgerald
Eric Joseph - JPMorgan
Judah Frommer - Morgan Stanley
Geoff Meacham - Citigroup
Tazeen Ahmad - Bank of America
Han Hu - Barclays
Peyton Bohnsack - TD Cowen
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the PTC Therapeutics First Quarter 2025 Earnings Conference Call. [Operator Instructions] Today’s conference is being recorded. I would now like to turn the conference over to Ellen Cavaleri, Head of Investor Relations. Please go ahead.
Ellen Cavaleri
Good afternoon and thank you for joining us today to discuss PTC Therapeutics first quarter 2025 corporate update and financial results. I am joined today by our Chief Executive Officer, Dr. Matthew Klein; our Chief Business Officer, Eric Pauwels; and our Chief Financial Officer, Pierre Gravier.
Today’s call will include forward-looking statements based on our current expectations. These statements are subject to certain risks and uncertainties and actual results may differ materially. Please review the slide posted on our Investor Relations website in conjunction with the call, which contains information about our forward-looking statements and our most recent annual report on Form 10-Q and annual report of Form 10-K filed with the SEC as well as our other SEC filings for a detailed description of applicable risks and uncertainties that could cause our actual performance and results to differ materially from those expressed or implied in these forward-looking statements.
Additionally, we will disclose certain non-GAAP information during this call. Information regarding our use of GAAP to non-GAAP financial measures and a reconciliation of GAAP to non-GAAP are available
- Read more current PTCT analysis and news
- View all earnings call transcripts